Our functional assays revealed that the anti-STAT3 mcDNA, 48 h post-transfection, has a promising IC50 of 13.48 nM - a low nanomolar concentration comparable or superior to previously reported decoy molecules used in head and neck cancer models (Sen et al., 2012). The gene discussed is STAT3; the disease is head and neck cancer.